Post by Elements Advisory
300 followers
๐ ๐๐๐ ๐๐๐๐ข๐ง๐๐ซ: ๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐ก๐๐ฅ๐ฅ๐๐ง๐ ๐๐ฌ & ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐๐จ๐ซ ๐๐๐๐ ๐๐ง๐ ๐๐๐๐ ๐๐ข๐จ๐๐ข๐๐๐ฅ ๐๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ ๐ Friday, June 19 | 11:00โ12:15 (CET) Many active substances used in PT11 (cooling systems) and PT12 (industrial slimicides) are still under evaluation in the EU Review Programme, but approvals are expected soon. โ ๏ธ This means companies need to proactively align their product strategy with upcoming BPR requirements and assessment practices. What will you gain from this session? โ Insight into current regulatory challenges in PT11 & PT12 assessments โ Designing robust efficacy testing programmes โ Understanding how to approach human health & environmental risk assessment (HHRA & ERA) โ Better anticipation of Review Programme timelines and common dossier pitfalls Speakers: โข CTGB (NL Competent Authority) - Barry Muijs โข Eurofins (Testing laboratory) - Michele Cavalleri โข Elements Advisory (ERA & HHRA expertise) - MARIA BAKA/Tineke De Wilde ๐ Register now to secure your spot and stay ahead of upcoming deadlines. https://lnkd.in/em_tPjFX If you canโt attend live, register anyway to receive the on demand recording afterwards.